25513782

PMC4320685

CRISPR RNA-guided nucleases (RGNs) are widely used genome-editing reagents, but methods to delineate their genome-wide, off-target cleavage activities have been lacking. Here we describe an approach for global detection of DNA double-stranded breaks (DSBs) introduced by RGNs and potentially other nucleases. This method, called genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq), relies on capture of double-stranded oligodeoxynucleotides into DSBs. Application of GUIDE-seq to 13 RGNs in two human cell lines revealed wide variability in RGN off-target activities and unappreciated characteristics of off-target sequences. The majority of identified sites were not detected by existing computational methods or chromatin immunoprecipitation sequencing (ChIP-seq). GUIDE-seq also identified RGN-independent genomic breakpoint 'hotspots'. Finally, GUIDE-seq revealed that truncated guide RNAs exhibit substantially reduced RGN-induced, off-target DSBs. Our experiments define the most rigorous framework for genome-wide identification of RGN off-target effects to date and provide a method for evaluating the safety of these nucleases before clinical use.

CDC Public Access

DP1 GM105378/DP/NCCDPHP CDC HHS/United States
DP1 GM105378/GM/NIGMS NIH HHS/United States
F32 GM105189/GM/NIGMS NIH HHS/United States
R01 AR063070/AR/NIAMS NIH HHS/United States
R01 AR063070/AR/NIAMS NIH HHS/United States
R01 GM088040/GM/NIGMS NIH HHS/United States
R01 GM088040/GM/NIGMS NIH HHS/United States